Literature DB >> 22433568

A new viscosupplement based on partially hydrophobic hyaluronic acid: a comparative study.

Ivana Finelli1, Ester Chiessi, Devis Galesso, Davide Renier, Gaio Paradossi.   

Abstract

A novel partially hydrophobized derivative of hyaluronic acid (HYADD® 4), containing a low number of C16 side-chains per polysaccharide backbone, provides injectable hydrogels stabilized by side-chain hydrophobic interactions. The rheological properties of Hymovis®, a physical hydrogel based on the hyaluronic acid derivative HYADD® 4, were evaluated using as reference a solution of the parent natural polysaccharide, hyaluronic acid. The rheological measurements were performed both in flow and oscillation regimes at the physiological frequency values of the knee, typically spanning the range from 0.5 Hz (walking frequency) to 3 Hz (running frequency). Moreover, the viscoelastic features of Hymovis® were compared with the market-available viscosupplementation products in view of its use in joint diseases.The different behavior of the investigated materials in crossover frequency measurements and in structure recovery experiments can be explained on the basis of the structural and dynamic properties of the polymeric systems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22433568     DOI: 10.3233/BIR-2011-0596

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  12 in total

1.  Hyaluronic acid in the management of osteoarthritis: injection therapies innovations.

Authors:  Valter Santilli; Marco Paoloni; Massimiliano Mangone; Federica Alviti; Andrea Bernetti
Journal:  Clin Cases Miner Bone Metab       Date:  2016-10-05

2.  Intra-articular Hymovis injection for managing hip OA in active sportsmen. A 24-month observational retrospective clinical investigation.

Authors:  G Rando; R Pastorino
Journal:  J Clin Orthop Trauma       Date:  2021-09-14

3.  Intra-articular glenohumeral injections of HYADD®4-G for the treatment of painful shoulder osteoarthritis: a prospective multicenter, open-label trial.

Authors:  Giuseppe Porcellini; Giovanni Merolla; Nicola Giordan; Paolo Paladini; Andrea Burini; Eugenio Cesari; Alessandro Castagna
Journal:  Joints       Date:  2016-01-28

4.  A new hydrogel for the conservative treatment of meniscal lesions: a randomized controlled study.

Authors:  Claudio Zorzi; Stefano Rigotti; Daniele Screpis; Nicola Giordan; Gianluca Piovan
Journal:  Joints       Date:  2016-01-28

5.  A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan.

Authors:  Margaret M Smith; Amy K Russell; Antonella Schiavinato; Christopher B Little
Journal:  J Inflamm (Lond)       Date:  2013-07-27       Impact factor: 4.981

6.  The effect of viscosupplementation on early-stage knee osteoarthritis: Clinical evaluation and assessment of cartilage in vivo with 7 T MRI.

Authors:  Lorenzo Andreani; Michele Giuntoli; Francesco Addevico; Giacomo Aringhieri; Mirco Cosottini; Stefano Marchetti
Journal:  J Clin Orthop Trauma       Date:  2021-05-08

7.  Elastoviscous Transitions of Articular Cartilage Reveal a Mechanism of Synergy between Lubricin and Hyaluronic Acid.

Authors:  Edward D Bonnevie; Devis Galesso; Cynthia Secchieri; Itai Cohen; Lawrence J Bonassar
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

8.  Early Efficacy of Intra-Articular HYADD® 4 (Hymovis®) Injections for Symptomatic Knee Osteoarthritis.

Authors:  Ferdinando Priano
Journal:  Joints       Date:  2017-07-28

9.  A Comparison Between Rheological Properties of Intra-articular Hyaluronic Acid Preparations and Reported Human Synovial Fluid.

Authors:  Mat Nicholls; Ajay Manjoo; Peter Shaw; Faizan Niazi; Jeffrey Rosen
Journal:  Adv Ther       Date:  2018-03-14       Impact factor: 3.845

10.  On the Dependence of Rheology of Hyaluronic Acid Solutions and Frictional Behavior of Articular Cartilage.

Authors:  David Rebenda; Martin Vrbka; Pavel Čípek; Evgeniy Toropitsyn; David Nečas; Martin Pravda; Martin Hartl
Journal:  Materials (Basel)       Date:  2020-06-11       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.